Search Within

Malin Lisa Hultcrantz

Formats
  1. Meeting Abstract (171)
  2. Journal Article (68)
  3. Research Letter (9)
  4. Guidelines (6)
  5. Review (3)
  6. Correspondence (2)
  7. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (260)
  2. Department of Medicine (260)
  3. Hematologic Malignancies, Division of (260)
  4. Myeloma (260)
  5. Sloan Kettering Institute Postdocs (260)
  6. Hematologic Malignancies Research (179)

More Groups

People
  1. Sham Mailankody (148)
  2. Neha Korde (145)
  3. Alexander Lesokhin (140)
  4. Hani Hassoun (135)
  5. Urvi Shah (125)
  6. Heather Landau (119)

More People

Years
  1. 2025 (8)
  2. 2024 (39)
  3. 2023 (51)
  4. 2022 (52)
  5. 2021 (30)
  6. 2020 (26)

More Years

Publications
  1. Blood (97)
  2. Clinical Lymphoma, Myeloma and Leukemia (50)
  3. Journal of Clinical Oncology (17)
  4. Blood Cancer Journal (13)
  5. Haematologica (10)
  6. Blood Advances (6)

More Publications

Publishers
  1. American Society of Hematology (103)
  2. Elsevier Inc. (55)
  3. Nature Publishing Group (21)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (10)
  6. American Association for Cancer Research (6)

More Publishers

Results (260)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update
    Meeting Abstract

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O'Byrne, L.; Powers Happ, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies
    Meeting Abstract

    Firestone, R.; Shekarkhand, T.; Patel, D.; Tan, C. R. C.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Korde, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Plinabulin to shorten neutropenia and improve quality of life peri-autologous hematopoietic cell transplant
    Meeting Abstract

    Shah, G. L.; Hanley, D.; Datta, A.; Kamrowski, A.; Chung, D. J.; Gupta, G. K.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; Korde, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Prevalence of smoldering multiple myeloma based on nationwide screening
    Journal Article

    Thorsteinsdóttir, S.; Gíslason, G. K.; Aspelund, T.; Rögnvaldsson, S.; Óskarsson, J. Þ; Sigurðardóttir, G. Á; Þórðardóttir, Á R.; Viðarsson, B.; Önundarson, P. T.; Agnarsson, B. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: A prospective observational cohort study
    Journal Article

    Korde, N.; Tavitian, E.; Mastey, D.; Lengfellner, J.; Hevroni, G.; Zarski, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; more...
    eClinicalMedicine (2023)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach
    Journal Article

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Flynn, J.; Salvatore, S. P.; Jaffer-Sathick, I.; Rossi, A. C.; Lahoud, O.; Hultcrantz, M.; Shah, U. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Systemic light chain amyloidosis, version 2.2023, NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D. Jr; Baljevic, M.; Campagnaro, E.; Castillo, J. J.; Costello, C.; D'Angelo, C.; Devarakonda, S.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma (RRMM): DREAMM-14
    Meeting Abstract

    Hultcrantz, M.; Kleinman, D.; Ghataorhe, P.; McKeown, A.; He, W.; Ling, T.; Jewell, R. C.; Byrne, J.; Eliason, L.; Scott, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Plinabulin after autologous hematopoietic cell transplant to decrease duration of neutropenia and improve quality of life peri-transplant
    Meeting Abstract

    Shah, G.; Shulman, L.; Hanley, D.; Chung, D.; Datta, A.; Dhar, P.; Gupta, G.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save